Crohn's Disease and Colitis Trial, Recruiting (NCT06758024)

Crohn's Disease and Colitis Trial, Recruiting NCT06758024 Sponsor: Pontificia Universidad Catolica de Chile Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06758024 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are an adult (18 or older) who is currently admitted to hospital with Crohn's disease, ulcerative colitis, or a similar inflammatory bowel disease.
You are having a moderate-to-severe flare-up that has not improved with steroid treatment given through a drip, and your gut specialist has decided you need a medicine called infliximab as part of your normal care.

Who may not be able to join:

You are under 18 years old.
You have an infection that is not currently under control.
You have had a permanent ileostomy (a bag attached to your abdomen) or a specific type of bowel surgery where the small intestine is connected directly to the back passage (confirm with trial site).
You are pregnant.
You do not wish to give your consent to take part in the study.
You are unable to follow the requirements of the study for any reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 56-22-3543838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06758024

Sponsor: Pontificia Universidad Catolica de Chile

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 56-22-3543838

More information: https://clinicaltrials.gov/study/NCT06758024

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are an adult (18 or older) who is currently admitted to hospital with Crohn's disease, ulcerative colitis, or a similar inflammatory bowel disease.
You are having a moderate-to-severe flare-up that has not improved with steroid treatment given through a drip, and your gut specialist has decided you need a medicine called infliximab as part of your normal care.

Who may not be able to join:

You are under 18 years old.
You have an infection that is not currently under control.
You have had a permanent ileostomy (a bag attached to your abdomen) or a specific type of bowel surgery where the small intestine is connected directly to the back passage (confirm with trial site).
You are pregnant.
You do not wish to give your consent to take part in the study.
You are unable to follow the requirements of the study for any reason (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Pontificia Universidad Catolica de Chile

Registry

ClinicalTrials.gov

Start date

24 January 2025

Est. completion

1 January 2026

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Infliximab optimal concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov